[go: up one dir, main page]

IT1227899B - Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni - Google Patents

Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Info

Publication number
IT1227899B
IT1227899B IT8823075A IT2307588A IT1227899B IT 1227899 B IT1227899 B IT 1227899B IT 8823075 A IT8823075 A IT 8823075A IT 2307588 A IT2307588 A IT 2307588A IT 1227899 B IT1227899 B IT 1227899B
Authority
IT
Italy
Prior art keywords
total
active substances
pharmaceutical active
partial coating
related compositions
Prior art date
Application number
IT8823075A
Other languages
English (en)
Italian (it)
Other versions
IT8823075A0 (it
Inventor
Achille Fiori
Alberto Natali
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT8823075A priority Critical patent/IT1227899B/it
Publication of IT8823075A0 publication Critical patent/IT8823075A0/it
Priority to FR8917074A priority patent/FR2670112A1/fr
Priority to DE3943242A priority patent/DE3943242A1/de
Application granted granted Critical
Publication of IT1227899B publication Critical patent/IT1227899B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
IT8823075A 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni IT1227899B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
FR8917074A FR2670112A1 (fr) 1988-12-23 1989-12-22 Enrobage total ou partiel de principes actifs pharmaceutiques et compositions correspondantes.
DE3943242A DE3943242A1 (de) 1988-12-23 1989-12-22 Vollstaendiger oder partieller ueberzug von pharmazeutischen wirkstoffen und entsprechende zusammensetzungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Publications (2)

Publication Number Publication Date
IT8823075A0 IT8823075A0 (it) 1988-12-23
IT1227899B true IT1227899B (it) 1991-05-14

Family

ID=11203507

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Country Status (3)

Country Link
DE (1) DE3943242A1 (de)
FR (1) FR2670112A1 (de)
IT (1) IT1227899B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
IN191482B (de) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
AU1169601A (en) * 1999-11-16 2001-05-30 Ranbaxy Laboratories Limited Taste masked oral compositions
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
IL157634A0 (en) 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms containing glucocorticosteroid
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2843881B1 (fr) * 2002-09-02 2006-06-02 Flamel Tech Sa Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
ES2314227T7 (es) 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
GB0320522D0 (en) 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
WO2005027878A1 (en) 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Delayed released dosage forms
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR101506627B1 (ko) * 2013-12-26 2015-03-30 현대약품 주식회사 아세브로필린 및 친수성 서방기제를 포함하는 서방형 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
DE3712058A1 (de) * 1987-04-09 1988-10-20 Boehringer Ingelheim Kg Theophyllinhaltige pharmazeutische formen

Also Published As

Publication number Publication date
FR2670112A1 (fr) 1992-06-12
DE3943242A1 (de) 1990-06-28
IT8823075A0 (it) 1988-12-23

Similar Documents

Publication Publication Date Title
IT1227899B (it) Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
IT8721253A0 (it) Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi.
FI952178L (fi) Jauhepinnoitekoostumukset ja niiden käyttö
BR1100329A (pt) Composto e formulação farmacêutica
BR1100824A (pt) Composto e composição farmacêutica
FR2636532B1 (fr) Compositions pharmaceutiques
DE59308338D1 (de) Kosmetische oder pharmazeutische Zubereitungen
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
IT8748729A0 (it) Idrosoli di sostanze farmacologicamente attive e composizioni farmaceutiche che li contengono
FI945731A0 (fi) Tiatsolidiinijohdannaiset ja farmaseuttiset koostumukset, jotka sisältävät niitä
FI945975L (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
ITRM910189A0 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
DE59407193D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ES2023286B3 (es) Composicion cosmetica o farmaceutica de uso cutaneo y procedimiento para la preparacion de tal composicion
BR9406747A (pt) Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica
FI20001777A7 (fi) Substituoidun triatsolin sulfaattisuola ja sen farmaseuttisia koostumuksia
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
NO305750B1 (no) Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene
FR2634764B1 (fr) Heterocycles oxaza et compositions pharmaceutiques les contenant
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
BR9307697A (pt) Composições contendo cafeína e s(+)-ibuprofeno ou s(+)-flubiprofeno ou s(+)-quetoprofeno
IT8547765A1 (it) Derivato di cefalosporina composizione farmaceutica che lo contiene e relativo procedimento di preparazione ed applicazione
EE9400182A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
IT1191986B (it) Derivati naftalenici di benzonorbornene loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 2

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 2, 19911211; POLI INDUSTRIA CHIMICA S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931230